The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora(Duke University), Svati H. Shah(Center for Human Genetics), Ivan Spasojević(Duke Medical Center), Shazia Ali(Duke Medical Center), Carol R. Reed(MaineHealth), Benjamin A. Salisbury(MaineHealth), Geoffrey S. Ginsburg(Duke Medical Center)
Cited by 503
Abstract
Related Papers
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Yoav Benjamini, Yosef Hochberg|Journal of the Royal Statistical Society Series B (Statistical Methodology)|1995|108k
<i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study
The SEARCH Collaborative Group|New England Journal of Medicine|2008|2k
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
Marja K. Pasanen, Hanna Fredrikson, Pertti J. Neuvonen et al.|Clinical Pharmacology & Therapeutics|2007|430